$7.10
-0.02-0.28%
At close: -
$7.10
0.000.00%
After Hours: Dec 20, 4:01 PM EDT
Comments
Loading...
EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock, Earnings Estimates, EPS, And Revenue
EyePoint Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 6
EPS Estimate
$-0.600
Quarterly Revenue Estimate
$9.9M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$45.7M
Analyze the earnings history of EyePoint Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
EyePoint Pharmaceuticals (EYPT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $-0.54 | $-0.55 | 1.82 % |
| Jun 2024 | 2024-08-07 | $-0.58 | $-0.52 | -11.5 % |
| Mar 2024 | 2024-05-08 | $-0.55 | $-0.42 | -30.9 % |
| Dec 2023 | 2024-03-07 | $-0.33 | $-0.49 | 32.6 % |
EyePoint Pharmaceuticals (EYPT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $10.52M | $9.93M | 5.98 % |
| Jun 2024 | 2024-08-07 | $9.48M | $9.59M | -1.18 % |
| Mar 2024 | 2024-05-08 | $11.68M | $9.92M | 17.8 % |
| Dec 2023 | 2024-03-07 | $14.03M | $8.90M | 57.6 % |
FAQ
When is EyePoint Pharmaceuticals (NASDAQ:EYPT) reporting earnings?
EyePoint Pharmaceuticals (EYPT) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for EyePoint Pharmaceuticals (NASDAQ:EYPT)?
The Actual EPS was $-0.54, which beat the estimate of $-0.55.
What were EyePoint Pharmaceuticals’s (NASDAQ:EYPT) revenues?
The Actual Revenue was $10.5M, which beat the estimate of $9.9M.
Browse earnings estimates, EPS, and revenue on all stocks.